Bromperidol
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
|
|
Clinical data | |
Trade names | Bromidol, Bromodol |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
Identifiers | |
CAS Number | 10457-90-6 |
ATC code | N05AD06 (WHO) |
PubChem | CID: 2448 |
ChemSpider | 2354 |
UNII | LYH6F7I22E |
KEGG | D01101 |
ChEMBL | CHEMBL28218 |
Chemical data | |
Formula | C21H23BrFNO2 |
Molecular mass | 420.315 g/mol |
|
|
|
|
(what is this?) (verify) |
Bromperidol (marketed as Bromidol, Bromodol) is a butyrophenone derivative. It is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia. It was discovered at Janssen Pharmaceutica in 1966.
References
- Poldinger W, Bures E, Haage H, Clinical study with bromperidol, a new butyrophenone derivative, Int Pharmacopsychiatry. 1977;12(1):20-4.
- Dubinsky B, McGuire JL, Niemegeers CJ, Janssen PA, Weintraub HS, McKenzie BE, Bromperidol, a new butyrophenone neuroleptic: a review, Psychopharmacology (Berl). 1982;78(1):1-7.
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Alcohols
- Belgian inventions
- Bromoarenes
- Butyrophenone antipsychotics
- Fluoroarenes
- Janssen Pharmaceutica
- Piperidines
- Typical antipsychotics
- Nervous system drug stubs